The long-term survival of simultaneous pancreas and kidney transplant with basiliximab induction therapy

Clinical Transplantation

Volumn 21, Issue 5, 2007, Pages 583-589

  Zhang, Rubin ^a,b   Florman, Sandy ^a   Devidoss, Sharmila ^a   Zarifian, April ^a   Killackey, Mary ^a   Paramesh, Anil ^a   Fonseca, Vivian ^a   Batuman, Vecihi ^a   Hamm, L Lee ^a   Slakey, Douglas ^a  

^a Tulane Center for Abdominal Transplantation   (United States)

^b NONE   (United States)

Author keywords

Basiliximab; Induction theraphy; Interleukin 2 receptor antibody; Kidney; Pancreas transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INCIDENCE; INFECTION; KIDNEY PANCREAS TRANSPLANTATION; LEUKOPENIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; SURVIVAL TIME;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; SURVIVORS; TRANSPLANTATION CONDITIONING;

EID: 34548643586     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00692.x     Document Type: Article

References (22)

1. K elly WD, Lillehei RC, Merkel FK et al. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967: 61: 827.
2. Cohen DJ, St Martin L, Christensen LL et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006: 6: 1153.
3. Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States 2004. Am J Transplant 2005: 5: 843.
4. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005: 19: 433.
5. Cantarovich D, Karam G, Giral -Classe M et al. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int 1998: 54: 1351.
6. Odorico JS, Pirsch JD, Knechtle SJ et al. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Transplantation 1998: 66: 1751.
7. Bechstein WO, Malaise J, Saudek F et al. Efficacy and safety of tacrolimus compared with cyclosporine microemusion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial. Transplantation 2004: 77: 1221.
8. Malaise J, Saudek F, Boucek P et al. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: The EURO-SPK 3-year results. Transplant Proc 2005: 37: 2843.
9. Corry RJ, Shapiro R, Egidi MF et al. Pancreas transplantation without antibody therapy. Transplant Proc 1998: 30: 299.
10. Reddy KS, Stratta RJ, Shokouh-Amiri H et al. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. Transplantation 2000: 69: 49.
11. Burke GW, Ciancio G, Alejandro R et al. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. Transplant Proc 1998: 30: 1544.
12. Jordan ML, Shapiro R, Gritsch HA et al. Long-term results of pancreas transplantation under tacrolimus immunosuppression. Transplantation 1999: 67: 266.
13. S tratta RJ, A lloway RR, L o A et al. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regiments of Daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: Results at 3 years. Transplant Proc 2005: 37: 3531.
14. Huurman VA, Kalpoe JS, van de Linde P et al. Choice of antibody immunotherapy influences cytomagalovirus viremia in simultaneous pancreas-kidney transplant recipients. Diabetes Care 2006: 29: 842.
15. Kaufman DB, Burke GW, Bruce DS et al. Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transpant 2003: 3: 855.
16. Burke GW, Kaufman DB, Millis JM et al. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: Three-year results. Transplantation 2004: 77: 1269.
17. Hesse UJ, Troisi R, Jacobs B et al. A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants. Clin Transplant 2000: 14: 340.
18. Stratta RJ, Alloway RR, Lo A et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: Primary endpoint analysis of a multicenter, randomized study. Transplantation 2003: 75: 1260.
19. Bilous RW, Mauer SM, Sutherland DE et al. The effect of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989: 321: 80.
20. L arsen JL, R atanasuwan T, B urkman et al. Carotid intima media thickness decreases after pancreas transplantation. Transplantation 2002: 73: 936.
21. Drognitz O, Benz S, Pfeffer F et al. Long-term follow-up of 78 simultaneous pancreas-kidney transplants at a single center institution in Europe. Transplantation 2004: 78: 1802.
22. Reddy KS, Stablein D, Taranto S et al. Long-term survival following simultaneous kidney-pancreas transplantation vs. kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003: 41: 464.